möglich sobald bei der ZB eingereicht worden ist.
Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage.
FASEB J. 15, 1822-+ (2001)
Angiotensin (Ang)-II induces vascular wall inflammation by activating NF-kappaB. Aspirin inhibits IKK beta in vitro; however, the in vivo relevance of the phenomenon is unclear. We tested the hypothesis that aspirin protects from Ang II-induced endorgan damage by inhibiting NF-kappaB activation in vivo. Rats harboring human renin and angiotensinogen genes received high- (600 mg/kg/day) or low- (25 mg/kg/day) dose aspirin. High-dose aspirin reduced mortality, cardiac hypertrophy, fibrosis, and albuminuria independent of blood pressure, whereas both doses reduced cyclooxygenase activity. High-dose aspirin inhibited NF-kappaB and AP-1 activation and inflammation in heart and kidney. These in vivo results serve to explain the clinical utility of high- dose aspirin in inflammatory disorders and suggest additional therapeutic avenues that may be relevant to cardiovascular disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.480
1.383
80
87
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Angiotensin Ii ; Aspirin, Nf-kappa B ; End-organ Damage ; Inflammation; Nonsteroidal Antiinflammatory Drugs; Sodium-salicylate; Transcription Factor; Kinase-activity; Tissue Factor; Ikk Complex; Activation; Mechanisms; Cells; Renin
Sprache
englisch
Veröffentlichungsjahr
2001
HGF-Berichtsjahr
0
ISSN (print) / ISBN
0892-6638
e-ISSN
1530-6860
Zeitschrift
FASEB Journal
Quellenangaben
Band: 15,
Heft: 8,
Seiten: 1822-+
Verlag
Wiley
Verlagsort
Bethesda, Md.
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-501792-001
PubMed ID
11481242
WOS ID
WOS:000169261200014
Erfassungsdatum
2001-09-30